secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001493152-23-018231
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics President, COO and Director Amy Broidrick to resign effective June 16, 2023
--------------------------------------------------------------------------------

- Amy Broidrick, President, Chief Strategy and Operating Officer, and director, submitted resignation effective June 16, 2023.
- Her departure is not related to any disagreement with the company on operations, policies, or practices.
- She will resign from all officer and director positions with the company and its subsidiaries.
- Company intends to enter into a separation agreement and general release with Ms. Broidrick.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223018231/0001493152-23-018231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223018231/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-018231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer